三款产品一级召回!飞利浦再陷监管风暴

新浪医药
11 Mar

2025年3月3日,美国FDA官网公告称,宣布将飞利浦(PHG.US)的血管内器械召回事件升级为一级召回(最严重级别),并要求其下架Tack血管植入物。这是继呼吸机、 LED 电池灯等产品召回后,飞利浦再次因安全隐患陷入监管风暴。▍严重不良反应频发,紧急召回飞利浦此次召回的产品是Tack血管内系统主要有三款,分别是粘性血管内系统(4F,1.5-4.5mm),150cm;粘性血管内系统(6F,3.5...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10